A Phase 3 Study of F14 for Management of Pain Following Total Knee Replacement
Public ClinicalTrials.gov record NCT05603832. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multicenter, Randomized, Double-Blind, Parallel Group Study of the Efficacy and Safety of a Single Administration of F14 for Postoperative Analgesia in Patients Undergoing Unilateral Total Knee Replacement
Study identification
- NCT ID
- NCT05603832
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Arthritis Innovation Corporation
- Industry
- Enrollment
- 151 participants
Conditions and interventions
Conditions
Interventions
- F14 Drug
- 0.25 % Bupivacaine HCl Drug
- Acetaminophen Drug
- Methocarbamol Drug
Drug
Eligibility (public fields only)
- Age range
- 45 Years to 80 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 16, 2022
- Primary completion
- Nov 21, 2023
- Completion
- Aug 22, 2024
- Last update posted
- Dec 17, 2025
2022 – 2024
United States locations
- U.S. sites
- 7
- U.S. states
- 5
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Woodland International Research Group | Little Rock | Arkansas | 72211 | — |
| Phoenix Clinical Research | Tamarac | Florida | 33321 | — |
| The Orthopedic Center | Tulsa | Oklahoma | 74104 | — |
| HD Research - First Surgical Hospital | Bellaire | Texas | 77401 | — |
| HD Research - Legent Orthopedic Hospital | Carrollton | Texas | 75006 | — |
| Endeavor Clinical Trials | San Antonio | Texas | 78240 | — |
| CenExel JBR | Salt Lake City | Utah | 84107 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05603832, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 17, 2025 · Synced Jun 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05603832 live on ClinicalTrials.gov.